This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Apr;59(4):1594-5.

doi: 10.1046/j.1523-1755.2001.00661.x.

Bone mass evolution after renal transplantation

E Goffin, J P Devogelaer, G Depresseux, C van Ypersele de Strihou

PMID: 11260428
DOI: 10.1046/j.1523-1755.2001.00661.x

Free article

Comment

Bone mass evolution after renal transplantation

E Goffin et al. Kidney Int. 2001 Apr.

Free article

. 2001 Apr;59(4):1594-5.

doi: 10.1046/j.1523-1755.2001.00661.x.

Authors

E Goffin, J P Devogelaer, G Depresseux, C van Ypersele de Strihou

PMID: 11260428
DOI: 10.1046/j.1523-1755.2001.00661.x

No abstract available

PubMed Disclaimer

Comment in

Bone remodeling effect of cyclosporine protects against steroid-induced osteopenia.
Westeel FP, Mazouz H, Oprisiu R, Fournier A. Westeel FP, et al. Kidney Int. 2001 Jul;60(1):380. doi: 10.1046/j.1523-1755.2001.00813.x. Kidney Int. 2001. PMID: 11422777 No abstract available.

Comment on

Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP, Mazouz H, Ezaitouni F, Hottelart C, Ivan C, Fardellone P, Brazier M, El Esper I, Petit J, Achard JM, Pruna A, Fournier A. Westeel FP, et al. Kidney Int. 2000 Oct;58(4):1788-96. doi: 10.1046/j.1523-1755.2000.00341.x. Kidney Int. 2000. PMID: 11012914 Clinical Trial.

Similar articles

Bone remodeling effect of cyclosporine protects against steroid-induced osteopenia.
Westeel FP, Mazouz H, Oprisiu R, Fournier A. Westeel FP, et al. Kidney Int. 2001 Jul;60(1):380. doi: 10.1046/j.1523-1755.2001.00813.x. Kidney Int. 2001. PMID: 11422777 No abstract available.
Arterial hypertension in renal transplantation.
Sandrini S, Gaggia P, Bracchi M, Gaggiotti M, Brunori G, Maiorca R. Sandrini S, et al. Contrib Nephrol. 1996;119:16-25. doi: 10.1159/000425443. Contrib Nephrol. 1996. PMID: 8783585 Review. No abstract available.
Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
Marcén R, Galeano C, Fernández-Rodriguez A, Jiménez-Alvaro S, Teruel JL, Rivera M, Burgos FJ, Quereda C. Marcén R, et al. Transplant Proc. 2010 Oct;42(8):3055-7. doi: 10.1016/j.transproceed.2010.08.002. Transplant Proc. 2010. PMID: 20970609
Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
Buchholz B, Korn A. Buchholz B, et al. Transplant Proc. 1996 Aug;28(4):2187-8. Transplant Proc. 1996. PMID: 8769195 Clinical Trial. No abstract available.
Mechanism of transplantation-associated bone loss.
Sprague SM. Sprague SM. Pediatr Nephrol. 2000 Jul;14(7):650-3. doi: 10.1007/s004670000359. Pediatr Nephrol. 2000. PMID: 10912536 Review.

See all similar articles

Cited by

Comparison of calcium and alfacalcidol supplement in the prevention of osteopenia after kidney transplantation.
Berczi C, Asztalos L, Kincses Z, Balogh A, Löcsey L, Balázs G, Lukács G. Berczi C, et al. Osteoporos Int. 2003 Jun;14(5):412-7. doi: 10.1007/s00198-003-1389-0. Epub 2003 Apr 16. Osteoporos Int. 2003. PMID: 12730763

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information